Loading...

APC anti-mouse CD45.2 Antibody

Pricing & Availability
Clone
104 (See other available formats)
Regulatory Status
RUO
Other Names
Ly-5.2, LCA
Isotype
Mouse (SJL) IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
104_APC_122607
C57BL/6 mouse splenocytes stained with 104 APC
  • 104_APC_122607
    C57BL/6 mouse splenocytes stained with 104 APC
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
109813 25 µg 27€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
109814 100 µg 93€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45.2 is an alloantigen of CD45, expressed by Ly5.2 bearing mouse strains (e.g., A, AKR, BALB/c, CBA/Ca, CBA/J, C3H/He, C57BL, C57BR, C57L, C58, DBA/1, DBA/2, NZB, SWR, 129). CD45, a member of the protein tyrosine phosphatase (PTP) family, is a 180-240 kD glycoprotein expressed on all hematopoietic cells except mature erythrocytes and platelets. There are multiple isoforms in the mouse that play key roles in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation states of the cell as well as specific cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
B10.S mouse thymocytes and splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD45.2 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

The 104 antibody does not react with mouse cells expressing the CD45.1 alloantigen. Additional reported applications (for the relevant formats) include: immunoprecipitation4, in vivo and in vitro blocking of B cell responses1,2, and immunohistochemical staining of acetone-fixed frozen sections3. 

Application References

(PubMed link indicates BioLegend citation)
  1. Yakura H, et al. 1983. J. Exp. Med. 157:1077. (Block)
  2. Yakura H, et al. 1986. J. Immunol. 136:2729. (Block)
  3. Suzuki K, et al. 2000. Immunity 13:691. (IHC)
  4. Shen FW, et al. 1986. Immunogenetics 24:146. (IP)
  5. Baldwin TA and Hogquist KA. 2007. J. Immunol. 179:837.
  6. Pascal V, et al. 2007. J. Immunol. 179:1751.
  7. Burman AC, et al. 2007. Blood 110:1064.
  8. Kincaid EZ, et al. 2007. J. Immunol. 179:3187.
  9. Phan TG, et al. 2007. Nature Immunol. 8:992.
  10. Nakano-Yokomizo T, et al. 2011. J. Exp Med. 208:1661. PubMed
  11. Wen T, et al. 2013. PNAS. 110:6067. PubMed
  12. Kohlmeier JE, et al. 2008. Immunity. 29:101. (FC) PubMed
Product Citations
  1. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  2. Zhang J, et al. 2015. PLoS One. 10:130441. PubMed
  3. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  4. Guo H, Cooper S, Friedman A, et al. 2017. PLoS One. 10.1371/journal.pone.0150809. PubMed
  5. Hirai T, et al. 2020. Immunity. 54(1):84-98.e5. PubMed
  6. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  7. Jayachandran R, et al. 2019. Immunity. 50:152. PubMed
  8. Shibata K, et al. 2022. Nat Commun. 13:6948. PubMed
  9. Stanzione M, et al. 2022. Sci Adv. 8:eabn1229. PubMed
  10. Gern BH, et al. 2021. Cell Host Microbe. 29(4):594-606.e6. PubMed
  11. Ferrari de Andrade L, et al. 2020. Cancer Immunol Res. 0.867361111. PubMed
  12. Boyd DF, et al. 2020. Nature. 587:466. PubMed
  13. Santamaria-Martínez A, et al. 2009. Exp Cell Res. 315:3004. PubMed
  14. Krummey SM, et al. 2020. Cell Reports. 30(5):1282-1291.e5.. PubMed
  15. Degn SE et al. 2017. Cell. 170(5):913-926 . PubMed
  16. Waide ML, et al. 2020. Cell Rep. 33:108503. PubMed
  17. Brandt S, et al. 2020. J Am Soc Nephrol. 31:2589. PubMed
  18. Liu W, et al. 2021. Cell Mol Immunol. 18:2660. PubMed
  19. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  20. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  21. Fuster JJ, et al. 2020. Cell Rep. 33:108326. PubMed
  22. Lu SX, et al. 2021. Cell. . PubMed
  23. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  24. Okuniewska M, et al. 2021. Cell Reports. 36(2):109368. PubMed
  25. Yamamoto K, et al. 2021. Cell Reports. 36(8):109576. PubMed
  26. Burrack KS et al. 2018. Immunity. 48(4):760-772 . PubMed
  27. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  28. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  29. Osman A, et al. 2021. Nat Immunol. 22:1152. PubMed
  30. Sugita J, et al. 2021. Nat Commun. 12:1910. PubMed
  31. Marangoni F, et al. 2021. Cell. . PubMed
  32. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  33. Guo Z, et al. 2016. Nat Commun. 7:10307. PubMed
  34. Brocq M, et al. 2014. J Immunol. 192:6120. PubMed
  35. Han CY, et al. 2020. Cell Reports. 31(13):107818. PubMed
  36. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  37. Levine LS, et al. 2021. Immunity. 54(4):829-844.e5. PubMed
  38. Arsiwala T, et al. 2022. Int J Mol Sci. 23:. PubMed
  39. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  40. Jutz S, et al. 2016. J Immunol Methods. 430:10-20. PubMed
  41. Zhou L, et al. 2020. Clin Cancer Res. 26:290. PubMed
  42. Kaplan BLF et al. 2018. Current protocols in toxicology. 75:11:00 25. PubMed
  43. Kleppe M et al. 2018. Cancer cell. 33(1):29-43 . PubMed
  44. Dufva O, et al. 2020. Cancer Cell. 38(3):380-399.e13. PubMed
  45. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  46. Chen X, et al. 2021. Cell Rep. 37:109991. PubMed
  47. Faulhaber LD, et al. 2022. Neurophotonics. 9:031917. PubMed
  48. Bei T, et al. 2021. Molecules. 26:. PubMed
  49. Mansell E, et al. 2020. Cell Stem Cell. . PubMed
  50. Toubal A, et al. 2020. Nat Commun. 3755:11. PubMed
  51. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  52. Kalinski AL, et al. 2020. Elife. 9:00. PubMed
  53. Markey K, et al. 2014. J Immunol. 192:5426. PubMed
  54. Markey K, et al. 2012. Blood. 119:5918. PubMed
  55. Woodworth JS, et al. 2017. Mucosal Immunol. 0.802083333. PubMed
  56. Cohen SB et al. 2018. Cell host & microbe. 24(3):439-446 . PubMed
  57. Xu X, et al. 2018. Cell. 175:1336. PubMed
  58. Palazon A, et al. 2017. Cancer Cell. . 10.1016/j.ccell.2017.10.003. PubMed
  59. Lim JE, et al. 2022. Front Oncol. 12:1045016. PubMed
  60. Schaefer K, et al. 2014. PLoS One. 9:114824. PubMed
  61. Gordon E, et al. 2015. Proc Natl Acad Sci U S A. 112: 13075 - 13080. PubMed
  62. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  63. Qin Q, et al. 2021. Cell Reports. 35(8):109161. PubMed
  64. Chen X, et al. 2020. Am J Pathol. 190:2056. PubMed
  65. Kondo M, et al. 2016. J Immunol. 196: 563 - 572. PubMed
  66. Guo H, et al. 2014. J Leukoc Biol. 96:419. PubMed
  67. Kimishima Y, et al. 2021. Nat Commun. 12:6177. PubMed
  68. Melo-Silva CR, et al. 2021. PLOS Pathogens. 17(5):e1009593. PubMed
  69. Borges da Silva H, et al. 2020. Immunity. 53(1):158-171.e6. PubMed
  70. Goldstein JM et al. 2019. Cell reports. 27(4):1254-1264 . PubMed
  71. Garaycoechea JI, et al. 2018. Nature. 553:171. PubMed
  72. Berghoff SA, et al. 2021. Nat Neurosci. 24:47. PubMed
  73. Mandal RK, et al. 2021. Cell Reports. 35(6):109094. PubMed
  74. Takizawa H, et al. 2011. J Exp Med. 208:273. PubMed
  75. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  76. Firl DJ et al. 2018. eLife. 7 pii: e33051. PubMed
  77. Zhang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  78. Agrawal M, et al. 2022. Blood. 140:1094. PubMed
  79. Kobia FM, et al. 2020. PLoS Biol. 18:e3000850. PubMed
  80. Winkler ES, et al. 2020. Cell. 182(4):901-918.e18. PubMed
  81. Maroni G, et al. 2019. Int J Mol Sci. 20. PubMed
  82. Düking T, et al. 2022. Sci Adv. 8:eabo7639. PubMed
  83. Koide S, et al. 2022. iScience. 25:103603. PubMed
  84. Pfirschke C, et al. 2020. Cell Rep. 32:108164. PubMed
  85. van der Poel CE, et al. 2019. Cell Rep. 29:2745. PubMed
  86. Habtetsion T et al. 2018. Cell metabolism. 28(2):228-242 . PubMed
  87. Nakazawa Y, et al. 2021. Elife. 10:. PubMed
  88. Xu W, et al. 2021. Immunity. 54(3):526-541.e7. PubMed
  89. Mandal RK, et al. 2020. BMC Biol. 83:18. PubMed
  90. Asada S, et al. 2018. Nat Commun. 9:2733. PubMed
  91. Rivet-Noor CR, et al. 2022. Sci Rep. 12:8594. PubMed
  92. Wu B, et al. 2022. Nat Commun. 13:2155. PubMed
  93. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  94. Harding CL, et al. 2020. Front Cell Infect Microbiol. 10:328. PubMed
  95. Wang X, et al. 2022. Elife. 11:. PubMed
  96. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  97. Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed
  98. Hirota K et al. 2018. Immunity. 48(6):1220-1232 . PubMed
  99. Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
  100. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  101. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  102. Radulovic V, et al. 2020. Cell Reports. 27(10):2826-2836.e5.. PubMed
  103. Patterson DG, et al. 2021. J Immunol. 207:1798. PubMed
  104. Okubo A, et al. 2021. Int J Mol Sci. 23:. PubMed
  105. Aggarwal N, et al. 2021. Cell Rep. 37:110170. PubMed
  106. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
RRID
AB_389210 (BioLegend Cat. No. 109813)
AB_389211 (BioLegend Cat. No. 109814)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets of the CD45.2 strain of mice

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules
Antigen References

1. Suzuki K, et al. 2000. Immunity 13:691.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45.2 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45.2 Reagents Request Custom Conjugation
Description Clone Applications
Biotin anti-mouse CD45.2 104 FC
FITC anti-mouse CD45.2 104 FC
PE anti-mouse CD45.2 104 FC
Purified anti-mouse CD45.2 104 FC,Block,IHC-F,IP
APC anti-mouse CD45.2 104 FC
Alexa Fluor® 488 anti-mouse CD45.2 104 FC
Alexa Fluor® 647 anti-mouse CD45.2 104 FC
Pacific Blue™ anti-mouse CD45.2 104 FC
Alexa Fluor® 700 anti-mouse CD45.2 104 FC
APC/Cyanine7 anti-mouse CD45.2 104 FC
PerCP anti-mouse CD45.2 104 FC
PerCP/Cyanine5.5 anti-mouse CD45.2 104 FC
PE/Cyanine7 anti-mouse CD45.2 104 FC
Brilliant Violet 421™ anti-mouse CD45.2 104 FC
Brilliant Violet 570™ anti-mouse CD45.2 104 FC
Brilliant Violet 650™ anti-mouse CD45.2 104 FC
Brilliant Violet 510™ anti-mouse CD45.2 104 FC
Brilliant Violet 785™ anti-mouse CD45.2 104 FC
Brilliant Violet 605™ anti-mouse CD45.2 104 FC
Purified anti-mouse CD45.2 (Maxpar® Ready) 104 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse CD45.2 104 FC
Brilliant Violet 711™ anti-mouse CD45.2 104 FC
Alexa Fluor® 594 anti-mouse CD45.2 104 IHC-F,SB
APC/Fire™ 750 anti-mouse CD45.2 104 FC
TotalSeq™-A0157 anti-mouse CD45.2 104 PG
TotalSeq™-B0157 anti-mouse CD45.2 104 PG
TotalSeq™-C0157 anti-mouse CD45.2 104 PG
Brilliant Violet 750™ anti-mouse CD45.2 104 FC
Spark Blue™ 550 anti-mouse CD45.2 104 FC
Spark NIR™ 685 anti-mouse CD45.2 104 FC
Spark UV™ 387 anti-mouse CD45.2 104 FC
Spark Blue™ 574 anti-mouse CD45.2 (Flexi-Fluor™) 104 FC
Spark Red™ 718 anti-mouse CD45.2 (Flexi-Fluor™) 104 FC
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account